Study Design. A controlled, interventional animal study. Objective. The aim of this study was to evaluate the effect of diabetes mellitus (DM) on radiculopathy due to lumbar disc herniation (LDH), by investigating pain-related behavior and the expression of tumor necrosis factor-alpha (TNF-a) and growthassociated protein 43 (GAP43) in type 2 diabetic rats following application of nucleus pulposus (NP) to the dorsal root ganglion (DRG). Summary of Background Data. Previous clinical studies suggested negative effects of DM on radiculopathy due to LDH, and that inflammation and nerve regeneration could interact with DM and radiculopathy. Methods. We applied autologous NP to the left L5 DRG of adult male Wistar rats and Goto-Kakizaki rats. Behavioral testing measured the mechanical withdrawal threshold of rats. We immunohistochemically evaluated the localization of ionized calcium-binding adapter molecule-1 (Iba-1), receptor of advanced glycation end products (RAGE), and TNF-a in DRGs. TNF-a and GAP43 expression levels in DRG were determined by quantitative real-time PCR and western blotting. Results. The mechanical withdrawal threshold significantly declined in the non-DM NP group compared with the non-DM sham group for 28 days, whereas the decline in threshold extended to 35 days in the DM NP group compared with the DM sham group. RAGE and TNF-a expression in DRGs was colocalized in Iba-1 positive cells. The non-DM NP rats had higher TNF-a protein expression levels versus the non-DM sham rats on day 7, and the DM NP group had higher levels versus the DM sham group on days 7 and 14. The non-DM NP group had higher GAP43 mRNA expression than the non-DM sham group for 28 days, while the DM NP group had a higher level than the DM sham group for 35 days. Conclusion. DM prolongs the pain-related behavior caused by NP. The prolonged inflammation and nerve regeneration could elucidate the pathogenesis of continuous pain of radiculopathy initiated by LDH.
L umbar disc herniation (LDH) is one of the most common conditions leading to radiculopathy. The high prevalence of diabetes mellitus (DM) in radiculopathy patients has been noted. [1] [2] [3] In radiculopathy due to LDH, patients with DM did not achieve significant improvement of their pain symptoms with surgical intervention relative to nonoperative treatment. 4 On the basis of these clinical findings, it is possible that DM has an unfavorable effect on radiculopathy, such as worsening or prolongation of symptoms. However, the underlying mechanisms of such a relationship between DM and radiculopathy are not known.
It has been demonstrated experimentally that the application of autologous nucleus pulposus (NP) induces morphologic and functional changes in the nerve root and painrelated behavior. [5] [6] [7] [8] [9] [10] In the pathogenesis of radiculopathy caused by NP, inflammation in the dorsal root ganglion (DRG) with upregulated tumor necrosis factor-alpha (TNF-a) expression was observed. [10] [11] [12] [13] [14] With regard to the effect of DM on inflammation, advanced glycation end products (AGEs) 15 and the receptor for AGEs (RAGE) 16 could lead to the high TNF-a expression through the NF-kB pathway. 17 To the best of our knowledge, these negative effects of DM have not been investigated using an NP-initiated radiculopathy model before the present study.
The Goto-Kakizaki (GK) rat 18 was established as a spontaneous type 2 DM model. 19 GK rats were produced by the selective breeding of rats with glucose intolerance, beginning with a nondiabetic Wistar rat colony. In GK rats, several complications caused by type 2 DM generally develop, for example, peripheral neuropathy, 20 retinal endothelium changes, 21 and nephropathy, similar to the clinical situation. 22 The widely used streptozocin-induced DM model results in the specific destruction of pancreatic b cells followed by acute hyperglycemia, 23, 24 a mechanism that is typical in type 1 DM. 25 As mild type 2 DM is the more clinically relevant condition, we chose GK rats as the model for the present study.
We hypothesized that DM could worsen or prolong radiculopathy symptoms triggered by LDH and that inflammation and nerve regeneration play important roles in the pathogenesis of radiculopathy with underlying DM. Our goal in the present study was to determine alterations in the expression of TNF-a and GAP43 in the DRG and painrelated behavior in NP-applied spontaneous DM rats.
MATERIALS AND METHODS

Animals
A total of 129 male Wistar rats (13 weeks old, 290-300 g; Japan SLC, Shizuoka, Japan) and 126 male GK rats (13 weeks old, 325-350 g; Japan SLC) were used. Animals were housed in plastic cages at room temperature (RT; 218C-248C) on a 12-hour light/dark cycle with free access to food and water. The GK rat is a spontaneous model of type 2 (noninsulin-dependent) diabetes without obesity. [18] [19] [20] In a previous study, the average plasma glucose level of 8-week-old males was 6.7 mmol/L in Wistar rats and 8.5 mmol/L in GK rats. 19 The animal experiments were carried out under the guidance of the Fukushima Medical University Animal Care and Use Committee and the Guidelines for Animal Experiments, and in accordance with the Japanese Government Law Concerning the Protection and Control of Animals.
Experimental Groups
Rats were divided into two surgical groups: the NP application group (NP group) and the sham-operated group (sham group). Naive rats were used as controls. The experimental groups and the overall workflow are summarized in Table 1 .
Surgical Procedure
A combination of 0.3 mL of medetomidine hydrochloride (1.0 mg/mL; Nippon Zenyaku Kogyo, Fukushima, Japan), 0.8 mL of midazolam (5.0 mg/mL; Astellas Pharma, Tokyo, Japan), and 1.0 mL of butorphanol tartrate (5.0 mg/mL; Meiji Seika Parma, Tokyo, Japan) was prepared as an anesthetic. Before surgery, the animals were anesthetized by intraperitoneal injection of 0.1 mL/100 g of body weight of the above-described mixed anesthetic. Rats were placed in a prone position and the facet joint between the left L5 and L6 was exposed. Following the left L5/L6 facetectomy, the left L5 DRG was exposed. In each rat in the NP group, autologous NP harvested from the disc of the coccygeal spine was applied to the left L5 DRG. 10, 13, 14, [26] [27] [28] In each rat in the sham group, the same surgical procedure was performed, but without NP application to the DRG.
Measurement of Mechanical Withdrawal Thresholds
Behavioral testing of mechanical withdrawal threshold in rats was performed using von Frey filaments 1 day before surgery as a baseline, and on postoperative days 1, 7, 14, 21, 28, 35, and 42 after surgery. The testing was performed in the same animals (n ¼ 11 in each group). The rat to be tested was placed individually in an acrylic cage with a mesh floor and allowed to acclimatize until cage exploration and major grooming activities ceased. The left lateral-plantar surface of the operated hind paw was stimulated with nine von Frey filaments The gram designations of the von Frey filaments were based on the manufacturer's ratings. Stimulation was initiated with the 1.0-g filament and was applied just until the filament bent for 3 seconds. If the rat did not withdraw its foot after stimulation, the next-stiffer filament was tested in the same manner. The response was considered positive if the hind limb lifted with either licking or shaking of the foot as an escape response. Lastly, 12 rats in the non-DM group were used for tissue samples after the test on day 35, as there was no difference in thresholds between the NP and sham groups in the non-DM animals.
Immunohistochemical Analysis
Immunohistochemical examinations were performed on day 7 postsurgery (n ¼ 4, each group). Rats were deeply anesthetized using isoflurane (Wako Pure Chemical Industries, Osaka, Japan) and perfused with 4% paraformaldehyde in 0.1 mol/L phosphate-buffered saline (PBS). After fixation, the left L5 DRG was removed and postfixed in the same fixative for 24 hours and subsequently embedded in paraffin. DRG sections (6 mm thickness) were cut and placed on slides.
Ionized calcium-binding adapter molecule-1 (Iba-1) was used for the identification of endoneurial macrophages, and antibodies against TNF-a and RAGE were used for doublelabeled immunohistochemistry with Iba-1. Sections were deparaffinized with xylene and 100% ethanol, and pretreated with Dako target retrieval solution (Dako North America, Carpinteria, CA) at 958C for 20 minutes to enhance immunoreactivity. After blocking with 2% normal goat serum applied for 1 hour at RT, rabbit anti-Iba-1 (1:2000; Wako) was applied overnight at 48C, followed by incubation for 1 hour at RT with goat anti-rabbit Alexa Fluor 555 (red) fluorescent antibody (1:200; ThermoFisher Scientific, Waltham, MA).
Next, 2% normal donkey or goat serum in PBS was applied to each section for 1 hour. Incubation with polyclonal goat anti-TNF-a antibody (1:100; R&D Systems, Minneapolis, MN) or monoclonal mouse anti-RAGE (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA) was performed overnight at 48C. The sections were rinsed in PBS and incubated for 1 hour at RT with donkey anti-goat (for TNF-a) or goat anti-mouse (for RAGE) Alexa Fluor 488 (green) (1:200; ThermoFisher Scientific). After rinsing, the sections were mounted on microscope slides using Vectashield Mounting Medium with DAPI (4 0 ,6-diamidino-2-phenylindole) (Vector Laboratories, Burlingame, CA).
Quantitative Real-time Polymerase Chain Reaction (qPCR)
We measured GAP43 mRNA levels in the DRG on postoperative days 7, 14, 28, and 35 (n ¼ 6, each group). The rats were rapidly decapitated under isoflurane anesthesia, and left L5 DRG were removed and immediately frozen in liquid nitrogen and stored at À808C. Frozen DRG (4 mg) were pulverized under liquid nitrogen and homogenized in 300 mL of TRI Reagent (Sigma-Aldrich, St. Louis, MO). Total RNA from DRG was extracted and purified using a PureLink RNA Mini Kit (ThermoFisher Scientific) per the manufacturer's protocol. Absorbance ratios of 260/280 nm and concentrations of total RNA were measured using a NanoDrop 2000 (ThermoFisher Scientific), and RNA integrity numbers 29 were assessed on an Agilent 2100 Bioanalyzer (Agilent Technologies) to confirm the quality of total RNA (Table 2) .
For each sample, 1 mg RNA was reverse-transcribed to complementary DNA (cDNA) using random hexamers and MultiScribe reverse transcriptase (ThermoFisher Scientific). qPCR was performed on a Mx3000P system (ThermoFisher Scientific). With a hydrolysis probe and primer mixture (TaqMan Gene Expression Assays; ThermoFisher Scientific), the following gene expression was detected:
GAP43: Rn01474579_m1, glyceraldehyde-3-phosphate (GAPDH): Rn01775763_g1. GAPDH was selected as an internal control. qPCRs (10 mL) were run in three replicates, including Brilliant III QPCR Master Mix (Agilent Technologies), primer/probe, and cDNA. The amplification program was as follows: heating at 958C for 10 minutes; 
Western Blotting
Expression of TNF-a protein on days 7 and 14, and GAP43 protein from day 7 to day 35 were examined by western blotting. Anesthetized rats were rapidly decapitated and the left L5 DRG were removed on postoperative days 7, 14, 28, and 35 (n ¼ 6, each group) and frozen in liquid nitrogen. Samples were homogenized in lysis buffer (#9803; Cell Signaling Technology, Danvers, MA) and prepared as previously described with minor modifications. 10, 14, 31 Samples were electrophoresed on a 12.5% polyacrylamide gel (BioRad Laboratories, Hercules, CA) and transferred to polyvinylidene difluoride membranes (Merck Millipore, Darmstadt, Germany). The membranes were blocked with 5% nonfat milk (Wako) followed by incubation with primary antibody in 5% bovine serum albumin (Wako) overnight at 48C.
The incubated primary antibodies were monoclonal mouse anti-TNF-a antibody (1:100; R&D Systems), polyclonal mouse anti-GAP43 antibody (1:1000; Merck Millipore), and monoclonal mouse anti-GAPDH antibody (1:1000; Santa Cruz Biotechnology). The membranes were washed in TBS containing 0.1% Tween, and incubated for 1 hour at RT with horseradish peroxidase-conjugated antimouse secondary antibody (1:5000; Santa Cruz Biotechnology). The blots were visualized using an enhanced chemiluminescence system (ImmunoStar Zeta; Wako). The positive bands of immunoblots were quantified by densitometry using an ImageQuant LAS 4000 with ImageQuant TL software (General Electric, Boston, MA). Optical densities were analyzed as a ratio against GAPDH as the internal control and were corrected as the ratio to the naive group.
Statistical Analysis
All measurements are expressed as means AE SD. Statistical analyses were performed using the Wilcoxon test and JMP software (SAS Institute, Cary, NC). P values <0.05 were considered significant.
RESULTS
Behavioral Testing
The non-DM NP group had significant reductions in the withdrawal threshold for 28 days after surgery compared with the non-DM sham group (P < 0.05). In comparison, the thresholds in the DM NP group were significantly reduced for 35 days compared with the DM sham group (P < 0.05; Figure 1 ).
TNF-a and RAGE Expression in Endoneurial Macrophages
In the DM NP group, TNF-a (B) and RAGE (E) were observed to be expressed in Iba-1 positive cells (A, D) (Figure 2 A-F) , while in the non-DM group, these were observed at low levels. In both the non-DM and DM sham groups, TNF-a and RAGE were not expressed in DRG.
Time Course of TNF-a Expression in the DRG
TNF-a expression was significantly increased in the non-DM NP group on day 7 compared with the non-DM sham group (P < 0.05). TNF-a expression was significantly higher in the DM NP group on days 7 and 14 than in the DM sham group (P < 0.05) (Figure 3 ).
Time Course of GAP43 Expression in the DRG
Quantitative real-time qPCR revealed that the non-DM NP group expressed significantly higher GAP43 mRNA for 28 days than the non-DM sham group (P < 0.05), whereas the DM NP group expressed higher GAP43 mRNA for 35 days than the DM sham group (Figure 4) . Western blotting showed that both DM and non-DM NP rats had higher amounts of GAP43 protein than the respective sham group for 35 days ( Figure 5 ).
DISCUSSION
There are two important results in the present study. First, DM prolonged the pain-related behavior induced by NP application to the DRG. Second, the prolongation of inflammation and nerve regeneration under the DM condition was related to the continuous pain. Although several clinical studies have referred to the negative effects of DM on radiculopathy, 1,2,4,32 no basic research has been conducted to investigate NP-induced neuropathic pain in a spontaneous DM model. Our present study revealed the novel finding that type 2 DM prolonged the decrease in withdrawal thresholds triggered by NP application, and this information will contribute to our understanding of the natural course of DM patients with LDH.
We observed herein that the prolongation of inflammation and nerve regeneration in DM animals was associated with continuous pain-related behavior. In studies of the pathology of NP-induced radiculopathy, it was revealed that NP application to the DRG resulted in high TNF-a levels in DRG cells, 11, 12 satellite cells, 10,13,14 and macrophages. 10, 28 Notably, the number of macrophages was increased in the DRG of an NP model, 10 and a large number of macrophages and colocalized TNF-a were observed in a dorsal root compressed model. 33 Moreover, recombinant TNF-a application caused a reduction in the withdrawal threshold, 34, 35 and anti-TNF-a antibody temporarily improved the withdrawal threshold. 36 These findings indicate that macrophages and TNF-a in the DRG play primary important roles in the pathogenesis of radiculopathy. In this study, TNF-a was expressed in macrophages and the TNF-a expression level was maintained longer in DM rats. Type 2 . TNF-a expression in the DRG. In the non-DM NP group, TNF-a protein expression was significantly higher than in the non-DM sham group on day 7 (P < 0.05). In the DM NP group, TNF-a expression was significantly higher than the DM sham group on days 7 and 14 (P < 0.05).
DM thus induced continued inflammation, and this prolonged inflammatory condition could produce the continuous pain-related behavior.
In studies using an NP applied model 26, 27 and disc punctured model, 37 upregulated ATF3 (which is a neuronal damage marker) 38 and GAP43 (which reflects neuronal regeneration 39 ) were observed in the DRG. In addition, streptozocin-induced type 1 DM rats showed delayed nerve regeneration in a sciatic nerve crush model, 40 an observation supported by a clinical study using skin biopsies of diabetic patients. 41 Since nerve damage could be the result of NP exposure, 11, 37, 42 due mainly to TNF-a, 11, 12, 42 the prolonged duration of inflammation observed in the present study could result in prolongation of nerve regeneration. Several investigations attempting to identify the detailed function of GAP43 in nerve regeneration are progressing. 39, 43, 44 Nevertheless, upregulated GAP43 expression levels could be used to discriminate painful phenotypes of diabetic neuropathy from nonpainful phenotypes. 45 In addition, pain-related nerve regeneration was observed as upregulated GAP43 in neuronal fibers. 45, 46 Examination of GAP43 mRNA and protein levels in this study indicated that maximal GAP43 expression in the DM NP group tended to shift to a later time point compared with the non-DM NP group. These results indicated that the underlying diabetes resulted in continuous inflammation initiated by NP application. Therefore, it is possible that the duration of nerve regeneration reflects the prolonged period of pain, and this prolongation could be caused by sustained TNF-a expression.
In this study, RAGE was expressed in macrophages, which also expressed TNF-a. AGE-RAGE is one of the accepted and essential pathways that contribute to the pathological changes observed in diabetic vascular complications. [47] [48] [49] Upregulated RAGE expression was observed in cells of the vessel wall, including endothelium, vascular smooth muscle cells, and invading macrophages.
50,51 RAGE expression was increased in podocytes 52 (glomerular epithelial cells in the kidney) and Mü ller cells 53 (glial cells in the retina). Similarly, in amyloid-rich tissues, the upregulation of RAGE was observed in neurons as well as mononuclear Figure 5 . GAP43 protein expression in the DRG. In the non-DM NP group, GAP43 protein expression was significantly higher than in the non-DM sham group from day 7 to day 35 (P < 0.05). The DM NP group also had significantly higher expression than the DM sham group from day 7 to day 35 (P < 0.05). GAP43 expression in the DM NP group was maximal on day 14, whereas maximal expression was observed on day 7 in the non-DM NP group. In the non-DM NP group, GAP43 mRNA levels were significantly higher than in the non-DM sham group from day 7 to day 28 (P < 0.05). In the DM NP group, the levels were significantly higher than the DM sham group from day 7 to day 35 (P < 0.05).
phagocyte elements, including microglia in the Alzheimer disease brain. 54 Moreover, RAGE is involved in the inflammatory response, including the latter NF-kB pathway, 17, 55, 56 and AGE is localized in the NP of diabetic mice. 57 Thus, in the type 2 DM rats used in the present study, it is probable that the underlying effect of the AGE-RAGE pathway in macrophages could result in the upregulated TNF-a expression.
Chronic DM results in AGEs deposition, which is generally considered to be irreversible 15 because of the characteristic feature of the Maillard reaction, which involves the repeated dehydration and condensation of Amadori products. 58 Because of this irreversibility, it could be difficult to identify new therapeutic points in AGEs. However, with regard to RAGE, blocking of this receptor could be an effective treatment to improve the pain of radiculopathy with DM. In addition, as RAGE is a multiligand receptor 56, 59, 60 of immune cells, including advanced oxidation protein products, amyloid b, transthyretin (Mac1), calgranulin (S100), heat shock proteins, and high-mobility group box-1 protein (HMGB-1), this pathway could also contribute to the pathogenesis of radiculopathy initiated by NP. Intriguingly, HMGB1 is one of the ligands of RAGE, and a positive effect of anti-HMGB1 antibody on radiculopathy caused by NP was previously revealed in a rat model. 28 The present study has some limitations. First, we measured the mechanical withdrawal threshold, as opposed to thermal testing or other behavioral testing methods that are associated with diabetic neuropathy. Second, we did not evaluate alterations in RAGE expression due to NP application. To evaluate the effect of deposited AGEs in NP as the ligand of RAGE, further studies focusing on NP using type 2 DM rats are required.
CONCLUSION
Type 2 DM prolonged radiculopathy symptoms initiated by NP application to the dorsal root ganglia. The prolongation of inflammation and nerve regeneration with DM is related to the sustained radiculopathy symptoms. Clinically, this pathogenesis of the continuous pain of radiculopathy with LDH in type 2 DM patients could be applied to the prediction of the course of pain as well as novel therapeutic targets.
Key Points
We used an NP applied model on type 2 diabetic rat to investigate pain-related behavior and the expression of TNF-a and GAP43 in dorsal root ganglion (DRG). In diabetes mellitus (DM) rats, NP application resulted in continuous pain-related behavior and prolonged the upregulations of TNF-a and GAP43. The prolonged inflammation and nerve regeneration may elucidate the pathogenesis of continuous pain of radiculopathy initiated by lumbar disc herniation (LDH) with DM.
RAGE could be one of the targets to improve this negative effect of DM on radiculopathy due to LDH.
